treat – Neuroscience

FDA approves Vonoprazan to treat erosive esophagitis

November 2, 2023 by Wilma

The U.S. Food and Drug Administration (FDA) approved Phathom Pharmaceuticals’ vonoprazan (Voquenza) on November 1, 2023 for the treatment of adults with erosive esophagitis (erosive GERD), a gastroesophageal reflux disease. The drug is expected to be commercially available by December 2023. The drug’s approval marks a critical moment for more… Continue Reading FDA approves Vonoprazan to treat erosive esophagitis

Just telling yourself you were given ketamine could be enough to treat depression

October 27, 2023 by Wilma

For those suffering from stubbornly resistant forms of severe depression, ketamine is increasingly emerging as a solution. Years of research have hinted at the therapeutic potential of the dissociative anesthetic where other drugs have failed, promising the benefits of electroconvulsive therapy with far fewer risks. Despite all the enthusiasm, separating… Continue Reading Just telling yourself you were given ketamine could be enough to treat depression